Image

Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses

Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses

Recruiting
30-64 years
All
Phase N/A

Powered by AI

Overview

A randomised, double blinded, placebo-controlled crossover design clinical trial conducted at the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with overweight/ obesity. This study will measure the postprandial glucose and hormone responses to a high-carbohydrate meal with/ without a liquid tonic drink.

Description

Twenty individuals living with overweight/ obesity will be invited to attend the university laboratories on 2 separate occasions to participate in a postprandial (meal) challenge. Participants will consume the same high-carbohydrate meal on each visit, with or without a liquid tonic drink. This will be a cross-over design study, where participants will consume a placebo drink on the alternate visit. Participants will remain in the laboratory for 3-hours following the meal with a venous cannula in place, and have blood samples taken at regular timepoints. Blood samples will be analysed for glucose and appetite hormones. Participants will also wear a continuous glucose monitor throughout the period which encapsulates both study trials.

Eligibility

Inclusion Criteria:

  • Aged ≥30-64 years
  • Body Mass Index (BMI) of ≥27.0 kg/m2

Exclusion Criteria:

  • younger than 30 or 65 years or older,
  • a BMI less than 27.0 kg/m2,
  • have an allergy to any of the components in the plant-based tonic (see section 6),
  • pregnant or breastfeeding,
  • regularly skipping breakfast (i.e. not consuming breakfast on 5/7 days per week),
  • any diagnosed metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism), gastrointestinal (e.g. Crohn's) or cardiovascular (e.g. heart failure) abnormalities,
  • on an energy-restricted diet; significant weight fluctuation in the previous 3 months (>5% body weight),
  • high alcohol consumption (>14 units/week) (as per Alcohol Drink Guidelines),
  • medication that is used to treat blood glucose,
  • unable to attend in person testing sessions, or
  • unable or unwilling to provide blood samples.

Study details
    Overweight or Obese Adults

NCT07030010

Australian Catholic University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.